Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | PTPRC | P08575 | 1/20 | 0.38 |
| ▸ | LIG1 | P18858 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA9 | Q16790 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9222655 | 0.83 | CA12 (0.41) | MAPK1CA12CA1CA9ALDH1A1 | |
| SCHEMBL6196145 | 0.81 | KDM4E (0.41) | HPGDTSHRMAPK1HSD17B10ALDH1A1 | |
| SCHEMBL525712 | 0.80 | — | — | |
| SCHEMBL767167 | 0.80 | CTSS (0.36) | HPGDALDH1A1 | |
| SCHEMBL28613802 | 0.79 | ALDH1A1 (0.39) | HPGDALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL10397205 | 0.77 | AOC3 (0.32) | — | |
| SCHEMBL27495269 | 0.77 | AOC3 (0.32) | — | |
| SCHEMBL11171654 | 0.77 | AOC3 (0.32) | — | |
| SCHEMBL10397204 | 0.77 | AOC3 (0.32) | — | |
| SCHEMBL3840978 | 0.77 | HPGD (0.38) | HPGDTSHRMAPK1HSD17B10PTPRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1048 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112675908-A | Aerobic oxidation method of alcohols | 清华大学 | 2021-04-20 | — | — | CN | claimed |
| CN-112494484-A | Application of chiral tetraaryl substituted methane | 香港科技大学深圳研究院 | 2021-03-16 | — | — | CN | claimed |
| CN-107033139-B | Heteroaryl piperidine and heteroaryl based piperazine derivative as fungicide | 拜耳知识产权有限责任公司 | 2019-11-19 | — | — | CN | claimed |
| US-9975889-B2 | Heteroaryl piperidine and heteroaryl piperazine derivatives as fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2018-05-22 | — | — | US | claimed |
| US-9914728-B2 | Heteroaryl piperidine and heteroaryl piperazine derivatives as fungicides | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2018-03-13 | — | — | US | claimed |
| CN-107033139-A | It is used as the heteroaryl piperidine and heteroaryl based piperazine derivative of fungicide | 拜耳知识产权有限责任公司 | 2017-08-11 | — | — | CN | claimed |
| US-20170044154-A1 | HETEROARYL PIPERIDINE AND HETEROARYL PIPERAZINE DERIVATIVES AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-02-16 | — | — | US | claimed |
| US-20170044153-A1 | HETEROARYL PIPERIDINE AND HETEROARYL PIPERAZINE DERIVATIVES AS FUNGICIDES | BAYER INTELLECTUAL PROPERTY GMBH | 2017-02-16 | — | — | US | claimed |
| US-9457347-B2 | Olefin metathesis catalysts | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2016-10-04 | — | — | US | claimed |
| CN-102781937-B | As two (difluoromethyl) pyrazoles of sterilant | BAYER CROPSCIENCE AG (DE) | 2015-09-30 | — | — | CN | claimed |
| EP-0007605-B1 | A PROCESS FOR INVERTING THE CONFIGURATION IN OPTICALLY ACTIVE COMPOUNDS AND OPTICALLY ACTIVE INTERMEDIATE COMPOUNDS AND THEIR SALTS REQUIRED THEREFOR | CIBA-GEIGY AG (CH) | 1982-09-15 | — | — | EP | claimed |
| EP-0048887-A1 | Liquid crystal composition containing a pleochroic anthraquinone dye | MERCK PATENT GmbH (DE) | 1982-04-07 | — | — | EP | claimed |
| EP-0034116-A2 | N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines | BERLEX LABORATORIES, INC. (US) | 1981-08-19 | — | — | EP | claimed |
| EP-0007605-A1 | A process for inverting the configuration in optically active compounds and optically active intermediate compounds and their salts required therefor | CIBA-GEIGY AG (CH) | 1980-02-06 | — | — | EP | claimed |
| US-4182911-A | BETA-ADRENERGIC BLOCKING AGENTS | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1980-01-08 | — | — | US | claimed |
| US-4144340-A | ADRENERGIC BLOCKING AGENTS | DEUTSCHE GOLD UND SILBER- SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1979-03-13 | — | — | US | claimed |
| US-4113876-A | INSECTICIDES, FUNGICIDES, HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1978-09-12 | — | — | US | claimed |
| US-3969363-A | CARDIOVASCULAR DISORDERS | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-07-13 | — | — | US | claimed |
| US-3954836-A | INSECTICIDES, ACARICIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-05-04 | — | — | US | claimed |
| US-3935250-A | PESTICIDE | CIBA-GEIGY CORPORATION (US) | 1976-01-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044154-A1 | HETEROARYL PIPERIDINE AND HETEROARYL PIPERAZINE DERIVATIVES AS FUNGICIDES | PRXL2A, CYP1A1, CAT | HPGD 1872/4885TSHR 3091/4885MAPK1 2081/4885 |
| US-20170044153-A1 | HETEROARYL PIPERIDINE AND HETEROARYL PIPERAZINE DERIVATIVES AS FUNGICIDES | PRXL2A, CYP1A1, CAT | HPGD 1872/4885TSHR 3091/4885MAPK1 2081/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.